Transdermal H2S Sensing Device for Monitoring Peripheral Artery Disease
Award amount
$215,724Program and phase
STTR · Phase IAward year
2014Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- EXHALIX, LLC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- C1NVZ5M6E319
- Solicitation number
- PA13-089
- Topic code
- NHLBI
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Genie:S: On-Demand Sulfide Synthesis and Delivery Platform Technology for Ischemia Therapy
- A Hydrogen Sulfide Delivery Technology for Organ Preservation Therapy
- HEALS™: An Active Hydrogen Sulfide Delivery Technique for Accelerated, Effective Wound Healing
- Transdermal H2S Sensing Device for Monitoring Peripheral Artery Disease
- Repair by Local Infusion of Sulfides (ReLIS™) for Treatment of Disadvantaged Surgical Incisions
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- DUCTUS ARTERIOSUS STENT TO IMPROVE CONGENITAL HEART DEFECT MORTALITY
- Head Up CPR and Aortic Occlusion to Improve Survival after Refractory Cardiac Arrest
- Free-Breathing Dynamic Cardiopulmonary Function Imaging System to use with Xenon MRI
- The Next Wave of Asthma Therapeutics
- Bearingless flux reversal motor for neonatal and pediatric extracorporeal life support applications
Research funding history
10 SBIR/STTR records share this UEI (2014–2025). Reported award amounts total $5,897,745. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, National Science Foundation